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While antineutrophil cytoplasmic antibody (ANCA) positivity has been documented in some patients with postinfectious
glomerulonephritis (PIGN) and is associated with more severe disease, antiphospholipid antibodies (APA) are not known to be
a common occurrence. We describe a child with severe acute kidney injury who was noted to have prolonged positivity of both
ANCA and APA; a renal biopsy showed noncrescentic immune complex mediated glomerulonephritis with subepithelial deposits
compatible with PIGN. He recovered without maintenance immunosuppressive therapy and at last follow-up had normal renal
function. We discuss the cooccurrence and implications of ANCA and APA in children with PIGN.
1. Background
Approximately 90% of patients with active granulomatosis
with polyangiitis, 70% of patients withmicroscopic polyangi-
itis, and 50% with Churg-Strauss syndrome are ANCA posi-
tive [1]. In addition to pauci-immune vasculitis, ANCA pos-
itivity has also been described in other glomerular diseases
including lupus nephritis, antiglomerular basement mem-
brane antibody disease, and much less commonly postinfec-
tious glomerulonephritis (PIGN) [2]. Anticardiolipin (aCL)
antibodies have been described predominantly in the setting
of lupus and primary antiphospholipid antibody syndrome
and are associated with a thrombotic risk; a single report
documented a high incidence of aCL antibodies during
the acute and convalescence periods of poststreptococcal
glomerulonephritis (PSGN), especially in children [3]. There
are no published reports on the lupus anticoagulant or APA
in the setting of PIGN. We report our experience with a
child with severe PIGN who had prolonged ANCA and APA
positivity and who recovered renal function with minimal
immunosuppression.
2. Case Report
An 8-year-old boy presented with severe oliguric acute
kidney injury after 10 days of vomiting. Eight days prior to
admission hewas started on amoxicillin for acute otitismedia
and sinusitis. The day prior to admission, due to persistent
vomiting, laboratory testing was obtained and revealed heavy
proteinuria and microscopic hematuria; serum chemistries
showed a potassium level of 6.3mmol/L (6.3mEq/L), a blood
urea nitrogen level of 58.5mmol/L (164mg/dL), and a serum
creatinine level of 884 𝜇mmol/L (10mg/dL). There was no
history of fever, sore throat, skin rash, or arthritis. Exam-
ination was notable for blood pressure of 143/81mmHg,
bulging of the right tympanic membrane, and mild edema
of both legs. Serologic testing revealed negative Hepatitis
serologies; his antinuclear antibody (ANA) was positive at
low titer of 1 : 80 and his ANCA IgG was positive at 1 : 160
with a peripheral ANCA (p-ANCA) staining pattern. Based
on these preliminary results, the patient was started on
hemodialysis and plasmapheresis and received high-dose
intravenous methylprednisolone. Further testing revealed
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that his antimyeloperoxidase antibodies (MPO) and serine
protease 3 (PR3) antibodies were both negative, as was his
antidouble strandedDNA antibody. AnAPA assay showed an
elevated IgM level for 𝛽-2-glycoprotein I antibody (64.1MPL,
normal < 15); aCL antibodies were not detected and a
Dilute Russel Viper Venom Time (DRVVT) was normal.The
complement C4 level was normal but his C3 level was low
at 0.07 g/L (7mg/dL) (normal 70–206mg/dL). The antistrep-
tolysinO titer and the streptozyme screenwere both negative,
as was the anti-DNAse B. Renal biopsy subsequently showed
diffuse proliferative noncrescentic glomerulonephritis with
“full house” immunofluorescence and numerous subepithe-
lial hump-like deposits with scattered subendothelial and
mesangial deposits. Based on a diagnosis of severe PIGN
and since his urine output has improved, his plasmapheresis
was discontinued after 3 treatments and his steroids rapidly
tapered. He was discharged after 11 days with improving real
function.
The complement C3 and serum creatinine normalized by
2 weeks; his urinalysis remained abnormal for much longer
and had normalized by 11 months. Other serologic testing
took longer to normalize. His ANCA took 4 months to
normalize; his ANA remained mildly elevated (1 : 40 to 1 : 80)
until 2 years after presentation; the last test to normalize
was the 𝛽-2-glycoprotein I antibody IgM that had remained
quite high (39.6–97.7MPL, normal < 15) and only became
negative 3.5 years later. Serial aCL antibody tests remained
negative. His DRVVT, which was normal at admission, was
elevated at 11 months and 23 months, consistent with the
presence of lupus anticoagulant; this normalized 3.5 years
after admission. At the patient’s last visit, 3.5 years after
admission he was in good health and not on any medica-
tions.
3. Discussion
p-ANCA positivity is a rare and poorly understood occur-
rence in PIGN. Ardiles et al. studied 210 patients with PSGN
and found 18 (9%) to be ANCA positive [2]. Of these, only
4 (all children) were p-ANCA positive while the rest had
an atypical staining pattern. None of the p-ANCA positive
patients had autoantibodies against PR3 and only 1 had
an antibody against MPO. In their study, ANCA positivity
correlated with a more severe disease course of PSGN. Kanai
et al. described a pediatric patient with severe crescentic
PSGN who also had p-ANCA positivity and MPO positivity
[4]; at 18 months, the patient’s renal function had improved
on long-term azathioprine and oral prednisolone, although
MPO titers remained elevated. They and others postulated
that MPO positivity may correlate with crescent formation
[5]. APA levels were not noted in either report.
Our patient had a prolonged elevation in ANCA and
𝛽-2-glycoprotein I antibody and low titer ANA, as well as
intermittent evidence of the lupus anticoagulant, which have
never been reported before in the setting of PIGN. It is not
clearwhether this generalized autoimmunitywas precipitated
by his renal injury or was the result of the infection that trig-
gered the glomerulonephritis. ANCA have been postulated
to be triggered by infectious agents, especially Staphylococcus
aureus which has several PR3 encoding gene complementary
sequences [1]. The presence of multiple antibodies could
also indicate polyclonal B cell stimulation due to molecu-
lar mimicry or unchecked neutrophil apoptosis, resulting
from the triggering infection. Lastly these may have been
incidental abnormalities, since a very small proportion of
healthy people, when screened, will have ANCA or APA;
however, this is typically seen in adults and, moreover, would
not be expected to resolve in parallel with an improvement
in our patient’s clinical and laboratory test abnormalities.
APA and also antibodies against 𝛽-2-glycoprotein I have
been noted in patients with viral, bacterial, and parasitic
infections and are often transient [6]; these antibodies have
been hypothesized to have a role in innate immunity, but
they can be associated with a thrombotic risk if persistently
elevated, are proinflammatory, and have the potential to
exacerbate inflammation-mediated tissue injury [7].
Although our patient was started on plasmapheresis and
corticosteroids while biopsy results were awaited; the plasma-
pheresis was stopped abruptly and steroids were quickly
tapered down. Steroids have no role in uncomplicated PIGN
and even in severe crescentic PIGN, their role is controversial.
Through this case we would like to bring to the attention
of pediatric nephrologists to the possible cooccurrence of
ANCA and APA in the setting of PIGN, especially chil-
dren presenting with severe disease. Whether these have a
pathogenic role in increasing the severity of tissue injury
remains to be determined; however, if persistent and when
associated with progressively worsening disease, considera-
tion should be given to measuring them and possibly using
immunosuppression and/or plasmapheresis to help in renal
recovery.
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